Exosens Stock Soars 3.5%, Boosted by a Record Contract with Prague
The French specialist in night vision and imaging technologies for defense significantly rebounds in mid-morning trading. The stock is recovering from its monthly decline following the announcement of a major contract signed with the Czech armed forces. This movement occurs in a generally declining SBF 120 market.
A Rebound Driven by the Czech Contract Signed Earlier This Week
Exosens stock gains 3.42% to €59.05, up from €57.10 the previous day. The stock is among the top performers in the SBF 120, even as the broader index falls by 0.26%. This movement extends the rebound that began on Monday after the multi-year agreement was signed with Brolis to supply the Czech armed forces with image intensifier tubes.
The order, the largest ever placed by Prague in this field, involves about 17,000 components to be delivered by 2032, providing the group with several years of visibility on a strategic segment. This breath of fresh air comes after a challenging month, with the stock still showing a decline of 13.35% over thirty days. However, the annual performance remains strong, with a gain of 46.34% over the year, driven by European defense equipment needs.
The Stock Approaches its 20-Day Moving Average After Rebounding from the €52.65 Support
The technical setup is gradually improving. The price returns to its 20-day moving average at €59.11, a crucial breakthrough to confirm a short-term recovery. The 50-day moving average remains higher, at €61.43, representing a gap of about 3.9% to fill to rebuild a medium-term bullish channel. Conversely, the stock maintains a comfortable cushion above its 200-day moving average at €54.93, with a 7.5% gap, indicating that the underlying trend is still intact.
The RSI at 43 indicates a neutral position, exiting the oversold zone that had prevailed at the end of June. The major technical support remains identified at €52.65, tested several times this month. The next resistance is at €69.20, corresponding to April's highs.